Case Report
Gout is a systemic disease that evolves from the deposition of monosodium urate crystals in tissues. These crystals can be accumulated and deposited in all tissues, forming tophi . Tophi typically occur around the joints, in the subcutaneous or dermal tissue. Frequent locations are the helix of the ear, olecranon bursa, hands, knees, feet, and fingers .
As gout tends to present as articular disease first, cutaneous gout forming tophi usually correlate with chronicity and uncontrolled disease. Sometimes, skin involvement appears as small, superficial, whitish and sometimes pustule-like lesions with increasing pain, swelling, erythema, and a tendency for ulceration . There are only few reports of cutaneous tophi of the soles.
We report a 33-year-old kidney transplant male patient under long-term immunosuppression and with a history of hyperuricemia and gout, who was referred to our dermatological outpatient unit with the presentation of whitish skin lesions on the soles of his feet, some of them similar to verrucous warts. The patient's medical history included a kidney transplantation at the age of 12 because of severe reflux nephropathy. He described the development of small painful indurated nodules on both soles within months, preceded by several episodes of inflammatory arthritis in the right knee, right ankle, left shoulder as well as the metacarpophalangeal joints of both hands. Medication included amlodipine, candesartan, tacrolimus, mycophenolic acid, and natriumhydrogencarbonate.
Physical examination revealed hyperkeratotic annular nodules and papules on both soles of the feet and toes, painful on palpation (Fig. A). Dermoscopy showed diffuse yellowish homogenous annular plaques with central scaly and partially hemorrhagic papules (Fig. B), reminding of verrucous warts. Serum creatinine level was at baseline at 175 μmol/L (range 59–104 μmol/L), estimated glomerular filtration rate was 43 mL/min/1.73 m2 (range >59 mL/min/1.73 m2), blood urea level was 15.5 mmol/L (range 3.2–7.3 mmol/L), serum urate concentration was 447 μmol/L (range 202–416 μmol/L), and calcium and serum phosphate levels were normal.
[IMAGE OMITTED. SEE PDF]
Because of its remarkable appearance, a biopsy was taken. Histology revealed dermal nodular deposits of amorphous pink material surrounded by a sparse granulomatous inflammation, consistent with the diagnosis of gout (Fig. C, arrow).
Treatment for suspected gout was started before referral and included colchicine 1 mg daily as well as high-dose glucocorticoids, leading to a rapid clinical improvement within few days.
Chronic gout with tophaceous changes on palms and soles can cause problems in differentiation from other skin diseases . Involvement of the hands has been reported in few cases, usually being associated with renal dysfunction and thiazide diuretics . To the best of our knowledge, there is only one other report that described a patient who developed abrupt pustular gouty tophi on soles and hands after an episode of arthritis .
The present case illustrates the development of tophaceous gout on the soles in a patient with post-transplant renal insufficiency, chronic immunosuppression, and hypertension. It highlights the need to consider tophaceous gout in patients with atypical papules or nodules on the soles, which sometimes can show deceptive similarities to viral warts. Timely recognition of these features facilitates prompt initiation of urate-lowering therapy, limiting future gout attacks.
Conflict of Interest
None declared.
Authorship
SB: reviewed the patient, performed the literature review and wrote the manuscript. DS, RB: reviewed the patient, reviewed and edited the manuscript. RH: supervised the research project, reviewed the patient, and reviewed and edited the manuscript.
Ragab, G., M. Elshahaly, and T. Bardin. 2017. Gout: an old disease in new perspective ‐ A review. J. Adv. Res. 8:495–511.
Zarbafian, M., and J. Dutz. 2017. Finger pad tophi in a patient with Raynaud phenomenon. JAAD Case Rep. 1:45–48.
Fam, A. G., and D. Assaad. 1997. Intradermal urate tophi. J. Rheumatol. 24:1126–1131.
Vázquez‐Mellado, J., A. Cuan, M. Magaña, C. Pineda, J. Cazarin, C. Pacheco‐Tena, et al. 1999. Intradermal tophi in gout: a case‐control study. J. Rheumatol. 26:136–140.
Apibal, Y., S. Jirasuthus, and S. Puavilai. 2009. Abruption pustular gouty tophi of palm and sole. J. Med. Assoc. Thai. 92:979–982.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright John Wiley & Sons, Inc. 2018
Abstract
Key Clinical Message
This case highlights the need to consider tophaceous gout in patients with post‐transplant renal insufficiency, chronic immunosuppression, and hypertension, who develop atypical papules or nodules on the soles, which can cause problems in differentiation from other skin diseases.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer





